Research

Providing solutions for professionals working in reproductive medicine

+ 500 scientific publications

+ 4 patents

Collaborative projects with internationally renowned centers

20 laboratories worldwide

Overview

Research
Development

The basis of our products lies in research intended to fulfill the needs of professionals and their patients.
All the research projects performed at Igenomix are intended for clinical use.
IGENOMIX actively works in research and has organized and participated in many national and international talks and conferences.
The result of this hard work has led to the publication of a large number of peer reviewed articles.

At IGENOMIX, we work to develop all phases of designing diagnostic tests. From the original concept, undertaking clinical studies, producing and analyzing results, to creating products that can be commercialized, Igenomix is committed to developing each test to be backed with scientific evidence.
In the Products Development Department, we do not merely adapt already established procedures, but we innovate to provide our patients with the best services.
The staff at IGENOMIX actively works in research and employ the most advanced techniques applied to reproductive genetics.

Patents

Application number: PCT/ES2009/000386
Gene expression profile as an endometrial receptivity marker (ERA)
07/22/2009

Application number: PCT/EP2020/060878
Leiomyosarcomas I

Improved methods for the early diagnosis of uterine leiomyomas and leiomyosarcomas.
17/04/20

Application number: EP21382915.34
Leiomyosarcomas II

Improved methods for the early diagnosis of uterine leiomyomas and leiomyosarcomas.
11/10/21

Application number: 62/686,621
Methods, compositions and kits for assessing endometrial transformation
06/18/2018

Projects

Our effort is now being supported by several financial agencies:

IVACE, PROGRAMA CERTIFICA-CV. CERTIFICACIÓN DE I+D+i 2017. (Expd. IMACPA/2017/125, IMACPA/2017/116, MACPA/2017/124, IMACPA/2017/124, IMACPA/2017/123, IMACPA/2017/122, IMACPA/2017/120, IMACPA/2017/119, IMACPA/2017/117, IMACPA/2017/88). Cuantía concedida: 14.705,43 €
IVACE, PROGRAMA HORIZONTE-CV 2017. Expd. IMAPEA/2017/21. Cuantía concedida: 13.050 €
IVACE, PROGRAMA CERTIFICA-CV. CERTIFICACIÓN DE I+D+i 2016. (Expd. IMACPA/2016/263, IMACPA/2016/264, MACPA/2016/266, IMACPA/2016/269, IMACPA/2016/272, IMACPA/2016/274). Cuantía concedida: 16.950 €
IVACE, PROGRAMA AYUDAS PLAN INTERNACIONALIZACIÓN. ITAPIN IT16 PLANES DE INTERNACIONALIZACIÓN PYME CV. REF. ITAPIN/2016/459. Cuantía concedida: 21.076,12€ Plan Estratégico de internacionalización de la empresa IGENOMIX SL.
FP7 People Programme: Marie Curie Actions Marie Curie Industry-Academia Partnerships and Pathways (IAPP), 2013-2016. SARM 324509. Genómica endometrial y embrionaria. Búsqueda de biomarcadores en reproducción asistida.
EUREKA-EUROSTAR, 2011-2014. CIIP-20112001. Estudios no invasivos de disfunción endometrial – nuevas perspectivas clínicas para infertilidad y diagnóstico de la endometriosis.
MINECO, Programa TORRES QUEVEDO Convocatorias 2012, 2013, 2014, 2015 y 2016.

Igenomix is in the media

Igenomix is not affiliated with any news outlet or publication identified above. News coverage does not constitute an endorsement of Igenomix or its products.